ReviewClinical pharmacology : advances and applications2017

Olaratumab: a platelet-derived growth factor receptor-α-blocking antibody for the treatment of soft tissue sarcoma.

Alexandra Pender et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.